DK163145C - Analogifremgangsmaade til fremstilling af 6-substituerede s-triazoloe3,4-aaaftalazin-derivater - Google Patents

Analogifremgangsmaade til fremstilling af 6-substituerede s-triazoloe3,4-aaaftalazin-derivater

Info

Publication number
DK163145C
DK163145C DK017983A DK17983A DK163145C DK 163145 C DK163145 C DK 163145C DK 017983 A DK017983 A DK 017983A DK 17983 A DK17983 A DK 17983A DK 163145 C DK163145 C DK 163145C
Authority
DK
Denmark
Prior art keywords
preparation
derivatives
triazoloe3
aaaphthalazine
substituted
Prior art date
Application number
DK017983A
Other languages
Danish (da)
English (en)
Other versions
DK17983A (da
DK17983D0 (da
DK163145B (da
Inventor
Emilio Occelli
Domenico Barone
Giorgio Tarzia
Adele Giunta
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK17983D0 publication Critical patent/DK17983D0/da
Publication of DK17983A publication Critical patent/DK17983A/da
Publication of DK163145B publication Critical patent/DK163145B/da
Application granted granted Critical
Publication of DK163145C publication Critical patent/DK163145C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK017983A 1982-01-18 1983-01-18 Analogifremgangsmaade til fremstilling af 6-substituerede s-triazoloe3,4-aaaftalazin-derivater DK163145C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18
GB8201273 1982-01-18

Publications (4)

Publication Number Publication Date
DK17983D0 DK17983D0 (da) 1983-01-18
DK17983A DK17983A (da) 1983-07-19
DK163145B DK163145B (da) 1992-01-27
DK163145C true DK163145C (da) 1992-06-22

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
DK017983A DK163145C (da) 1982-01-18 1983-01-18 Analogifremgangsmaade til fremstilling af 6-substituerede s-triazoloe3,4-aaaftalazin-derivater

Country Status (20)

Country Link
US (1) US4788186A (pt)
EP (1) EP0085840B1 (pt)
JP (1) JPS58124786A (pt)
KR (1) KR890000184B1 (pt)
AT (1) ATE22562T1 (pt)
AU (1) AU564026B2 (pt)
CA (1) CA1214168A (pt)
DE (1) DE3366494D1 (pt)
DK (1) DK163145C (pt)
ES (1) ES8601995A1 (pt)
FI (1) FI81350C (pt)
GR (1) GR78442B (pt)
HU (1) HU193033B (pt)
IE (1) IE55032B1 (pt)
IL (1) IL67697A (pt)
NO (1) NO161674C (pt)
NZ (1) NZ203021A (pt)
PH (1) PH21834A (pt)
PT (1) PT76107A (pt)
ZA (1) ZA83224B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
EP0915877A1 (en) * 1996-07-25 1999-05-19 MERCK SHARP & DOHME LTD. SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABA A?$g(a)5 RECEPTOR SUBTYPE
EA002436B1 (ru) * 1996-07-25 2002-04-25 Мерк Шарп Энд Домэ Лимитед Замещенные производные триазоло-пиридазина в качестве лигандов рецепторов гамк
WO1998050385A1 (en) * 1997-05-08 1998-11-12 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
WO1999036423A1 (en) * 1998-01-14 1999-07-22 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
US6579875B1 (en) * 1998-01-21 2003-06-17 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
HUP0100647A3 (en) * 1998-02-25 2003-03-28 Merck Sharp & Dohme Ltd Hoddes Substituted 1,2,4-triazolo[3,4-a]pyridazine and its pharmaceutical use
BR9908155A (pt) 1998-02-25 2000-10-31 Merck Sharp & Dohme Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
AU1816900A (en) 1998-11-12 2000-05-29 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
WO2002083064A2 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. A method of treating cancer
EP1496981A2 (en) * 2002-04-08 2005-01-19 Merck & Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
CA2578368C (en) * 2004-09-02 2013-07-02 Altana Pharma Ag Triazolophthalazines
BRPI0606379A2 (pt) * 2005-01-05 2009-06-23 Nycomed Gmbh triazolftalazinas
JP5130053B2 (ja) * 2005-01-05 2013-01-30 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
CN102791715B (zh) 2009-12-31 2016-04-27 卡洛斯三世国家癌症研究中心基金会 用作激酶抑制剂的三环化合物
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (pt) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
IE55032B1 (en) 1990-05-09
ES531458A0 (es) 1985-11-01
NO161674B (no) 1989-06-05
KR840003254A (ko) 1984-08-20
FI81350B (fi) 1990-06-29
FI830100L (fi) 1983-07-19
PT76107A (en) 1983-02-01
FI81350C (fi) 1990-10-10
DK17983A (da) 1983-07-19
DK17983D0 (da) 1983-01-18
JPS58124786A (ja) 1983-07-25
CA1214168A (en) 1986-11-18
PH21834A (en) 1988-03-17
US4788186A (en) 1988-11-29
AU564026B2 (en) 1987-07-30
JPH048428B2 (pt) 1992-02-17
NO161674C (no) 1989-09-13
ES8601995A1 (es) 1985-11-01
KR890000184B1 (ko) 1989-03-09
IL67697A (en) 1990-02-09
ZA83224B (en) 1983-10-26
FI830100A0 (fi) 1983-01-12
IL67697A0 (en) 1983-05-15
ATE22562T1 (de) 1986-10-15
DK163145B (da) 1992-01-27
DE3366494D1 (de) 1986-11-06
AU1055083A (en) 1983-07-28
GR78442B (pt) 1984-09-27
NZ203021A (en) 1986-05-09
EP0085840B1 (en) 1986-10-01
EP0085840A1 (en) 1983-08-17
HU193033B (en) 1987-08-28
NO830110L (no) 1983-07-19
IE830082L (en) 1983-07-18

Similar Documents

Publication Publication Date Title
DK163145C (da) Analogifremgangsmaade til fremstilling af 6-substituerede s-triazoloe3,4-aaaftalazin-derivater
NO164712C (no) Analogifremgangsmaate til fremstilling av metylendifosfonsyre-derivater.
DK162389C (da) Analogifremgangsmaade til fremstilling af 2-oe4-oe(4,4-dialkyl-2,6-piperidindion-1-yl)butylaa-1-piperazinylaapyrimidiner
DK267082A (da) Fremgangsmaade til fremstilling af et agglomereret, pulverformet maelkeprodukt
NO161558C (no) Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner.
DK93685A (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
DK281482A (da) Fremgangsmaade til fremstilling af 2-aryl-3,4-diazabicyclo(4.n.o)alken-(2)-on-5-forbindelser
DK162167C (da) Analogifremgangsmaade til fremstilling af mitosanderivater
NO158871C (no) Analogifremgangsmaate for fremstilling av pyridazinderivater.
IL64472A0 (en) Pharmaceutical compositions containing tricyclic cytosin derivatives,certain new compounds of this class and their production
IL66028A0 (en) Saturated aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them
IL60323A0 (en) Pseudotrisaccharide compounds,their preparation and their medicinal use
NO163529C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner.
DK49783A (da) Fremgangsmaade til fremstilling af panthenolderivater
AR231839A1 (es) Procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona
DK161067C (da) Analogifremgangsmaade til fremstilling af 1,8-dihydroxy-9-anthron-addukter
DK132283A (da) Fremgangsmaade til fremstilling af indolizino(8,7-b)indolderivater
NO160141C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater.
ES511836A0 (es) "procedimiento para la preparacion de nuevos a1-pirrolin-tiolactimeteres".
DK123685D0 (da) Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-(1,4)-benzodiazepinderivater
NO903181L (no) Analogifremgangsmaate ved fremstilling av 4-amino-6,7-dimetoksy-2(6,7-dimetoksy-1,2,3,4-tetrahydroisokinol-2-yl)kinolin.
ES516812A0 (es) Procedimiento de preparacion de nuevos derivados de pirrol.
DK365586D0 (da) Analogifremgangsmaade til fremstilling af 3,4,5-trihydroxypiperidinderivater
DK285284A (da) Analogifremgangsmaade til fremstilling af 3,4,5-trihydroxypiperidinderivater

Legal Events

Date Code Title Description
PBP Patent lapsed